Bovine viral diarrhoea virus (BVDV
Introduction
Bovine viral diarrhoea virus (BVDV) is a major cattle pathogen with a worldwide distribution, which, together with classical swine fever virus (CSFV) of pigs and border disease virus (BDV) of sheep, belongs to the genus Pestivirus of the family Flaviviridae . Many members of this family can cause severe human disease, such as hepatitis C virus, dengue virus and yellow fever virus (Pringle, 1998) . The pestivirus genome comprises positive-stranded RNA that is translated to form a single virus polyprotein, which, through cleavage by both host and virus proteases, gives rise to 11 or 12 mature viral proteins (NH # -N pro -C-E rns -E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH) (Rice, 1996) . E rns , E1 and E2 are glycoproteins found on the surface of the virion. E rns lacks a typical transmembrane domain and a proportion of this protein is secreted from infected cells into the extracellular environment (Rumenapf et al., 1993) and also contains a ribonuclease activity (Hulst et al., 1994 ; Schneider et al., 1993 ; Windisch et al., 1996) . The role of ribonuclease activity in the virus life cycle is not clear. It has been reported that a genetically engineered strain of CSFV, which lacks ribonuclease activity, induced cell death in swine kidney cells but the parent Author for correspondence : Munir Iqbal.
Fax j44 1635 577263. e-mail munir.iqbal!bbsrc.ac.uk virus did not (Hulst et al., 1998) . However, another mutant CSFV lacking ribonuclease activity was not cytopathogenic (Meyers et al., 1999) . Recently we have assigned an additional function to E rns : BVDV glycoprotein E rns binds to glycosaminoglycans (GAGs) on the cell surface (Iqbal et al., 2000) ; subsequently, this was also shown for E rns of CSFV (Hulst et al., 2000) .
Heparin is present in the form of heparan sulphate proteoglycans on the cell surface and a large number of viruses utilize heparan sulphate to mediate attachment and infection of target cells. Examples can be found within many virus families : for example, members of the families Flaviviridae (Chen et al., 1997 ; Hilgard & Stockert, 2000 ; Su et al., 2001) , Herpesviridae (Terry-Allison et al., 2001) and Picornaviridae (Jackson et al., 1996) ; human immunodeficiency viruses (Di Caro et al., 1999) , human respiratory syncytial virus (Martı! nez & Melero, 2000) , adenovirus types 2 and 5 (Dechecchi et al., 2001) ; and members of the genus Alphavirus (Byrnes & Griffin, 1998) . The binding of proteins and glycoproteins to GAGs is often mediated through heparin-binding domains (HBDs), which are found in a wide range of proteins and are characterized by an overall positive charge. Common structural motifs have been proposed : the sequences BBXB, XBBXBX and XBBBXXBX (where B designates a basic amino acid and X designates any other residue) have been suggested to act as heparin-binding regions (Hileman et al., 1998 ; Sobel et al., 1992) .
The amino acid sequence of E rns has two conserved sequences, %!'KKGK%!* and %)!KKLENKSK%)(, which closely match consensus HBD sequences. Here we examine whether these putative heparin-binding consensus sequences present in E rns are involved in E rns -GAG binding ; we describe their relative affinities for heparin and cell surface binding ; and the ability of mutated E rns to block BVDV infection.
Methods
Cells and viruses. Calf testes (CTe) cells were maintained in Eagle's minimum essential medium (EMEM) supplemented with 10 % BVDV-free foetal calf serum (FCS), 5 % lactalbumin hydrolysate and 0n1 % penicillin G and streptomycin (100 µg\ml). Insect cells (Schneider S2 ; Drosophila) were obtained from Invitrogen and grown at room temperature in DES expression medium (Invitrogen) containing 10 % FCS. Working stock (passage no. 12) of BVDV cytopathogenic (CP) virus strain Pe515 (Pocock et al., 1987) was prepared in CTe cells.
Site-directed mutagenesis of heparin-binding sites. The E rns gene was cloned previously into a Drosophila expression vector to produce pMT\BiP\E rns \V5-His, which represented the full-length E rns cDNA of BVDV (non CP) strain Pe515 corresponding to amino acids 268-494 of the BVDV polyprotein (Iqbal et al., 2000) . Specific mutation of positively charged amino acids in putative heparin-binding motifs of E rns was carried out to substitute lysine for uncharged amino acids (alanine, glycine or threonine). Mutagenesis was done by PCR using the Quick Change Site-Directed Mutagenesis kit (Stratagene) following the manufacturer's guidelines. The sequences of the mutagenic primers used for the constructs can be obtained from the authors upon request. Sequencing of mutagenized plasmids was carried out commercially (MWG-Biotech). A deletion mutant of E rns (∆480-494 E rns ), where the C-terminal 15 amino acids of mature E rns were deleted, was constructed by PCR and cloned into the DES expression vector pMT\BiP\V5-His (Invitrogen). The primers used were : 5h ATTCAAGTTACAAGATCT-GAAAATATAACA 3h (sense orientation), which corresponds to nucleotides 1178-1207 of the BVDV genome sequence modified to include a BglII recognition site (bold letters) on the 5h end of the E rns sequence ; and 5h CTTGTTTTCCAATCTAGATCCTAGTATCCC 3h (anti-sense orientation), which corresponds to nucleotides 1820-1849 of the BVDV genome sequence modified by the inclusion of an XbaI recognition site (bold letters). Plasmids (pMT\BiP\E rns \V5-His) containing the genes encoding wild-type, mutated or deleted E rns were individually co-transfected with a hygromycin-resistant selection vector pCoHYGRO (Invitrogen) at a ratio of 19 (pMT\BiP\E rns \V5-His) to 1 (pCoHYGRO) into insect (S2) cells using a Calcium Phosphate Transfection kit (Invitrogen), according to the supplier's instructions.
Expression and purification of wild-type and mutant E rns . Wild-type and mutant E rns glycoproteins were expressed and purified as described previously (Iqbal et al., 2000) . Briefly, Drosophila S2 cells harbouring the E rns gene were grown in Ultimate Insect serum-free medium (Invitrogen) and expression of V5-tagged E rns (E rns V5) was induced by the addition of 5 µM copper sulphate. The culture supernatants collected 72 h post-induction were dialysed against equilibration buffer (20 mM Tris-HCl, pH 7n8, and 500 mM NaCl) and subjected to nickel affinity chromatography (Probond, Invitrogen). The column was washed with 20 mM Tris-HCl, pH 6n0, containing 1n0 M NaCl and 50 mM imidazole and E rns was eluted with 20 mM Tris-HCl, pH 6n0, containing 300 mM imidazole. Fractions containing E rns V5 were pooled and the concentration of protein was determined using the Coomassie reagent (Pierce).
Binding of E
rns and its mutants to heparin. The relative affinity of wild-type and mutant E rns to immobilized heparin was determined by loading the S2 cell culture supernatants containing wild-type or mutant proteins onto a 1n0 ml heparin-agarose column (Sigma) equilibrated previously with 20 mM Tris-HCl, pH 7n8. The column was washed with equilibration buffer and eluted in 1n0 ml fractions with a stepwise gradient of increasing concentrations of NaCl (0n1-1n0 M) in equilibration buffer. Dilutions of each fraction were coated onto a 96-well ELISA plate at 4 mC overnight and then blocked with 5 % skimmed milk in PBS. E rns was detected using an anti-V5 antibody (a generous gift from Professor R. Randall, University of St. Andrews, Scotland, UK).
Cell surface binding assay. Confluent cell monolayers of CTe cells in 96-well plates were washed twice with PBS, fixed with 4 % paraformaldehyde in PBS for 45 min at room temperature and blocked overnight at 4 mC with blocking buffer (5 % normal goat serum and 0n01 % NaN $ in PBS). The cells were then incubated with 0n3 µg wildtype or mutant E rns in PBS in a total volume of 50 µl for 1 h at room temperature. Subsequently, the cells were washed three times with PBS. Bound wild-type and mutant E rns were detected with an anti-E rns monoclonal antibody (WB210, Veterinary Laboratories Agency) or an anti-V5 monoclonal antibody (ibid).
Inhibition of BVDV infection of cells by E
rns . Confluent monolayers of CTe cells growing in 6-well plates were rinsed twice with serum-free EMEM and pre-incubated with 500 µl serum-free EMEM containing recombinant wild-type E rns , mutant E rns or control protein at 37 mC. After 1 h, dilutions of 500 µl CP BVDV (75 p.f.u.) in serum-free EMEM were added to the wells. When the virus solution was added, the concentration of protein (wild-type E rns , mutant E rns or GFP\V5) was diluted to 20 µg\ml (the concentration at which inhibition was measured). The virus-protein mixture was further allowed to adsorb for 1 h at 37 mC, after which the cells were washed three times with EMEM and overlaid with maintenance medium containing 1 % agarose. The cells were then incubated at 37 mC for 3 days. The cells were stained with toluidine blue (0n1 % toluidine blue and 4 % formaldehyde in PBS) and the number of CP virus plaques was counted.
Ribonuclease activity of E
rns . Ribonuclease activity of wild-type and mutant E rns was carried out essentially as described by Hulst et al. (1994) . Briefly, the assay mixture (25 µl in total) contained 0n2 µg of purified wild-type or mutant E rns and 12n5 µg of yeast 16-23S RNA in 20 mM sodium acetate buffer, pH 4n5. The mixture was incubated at 37 mC for varying time-points (5-45 min) and the enzyme reaction was stopped by acid precipitation using 5 µl of 25% (v\v) HClO % containing 0n75 % (w\v) uranyl acetate. After cooling on ice for 10 min, the reaction mixture was centrifuged for 5 min at 10 000 g and the absorbance at 260 nm of the supernatant was measured. The specific ribonuclease activity was expressed as A #'! units per min per mg of E rns .
Results

Construction of E rns mutants
The BVDV glycoprotein contains two clusters of basic amino acids : %!'KKGK%!* (HBD-1), which exactly matches various viral and mammalian heparin-binding site sequences (Feldman et al., 1999 ; Hileman et al., 1998 ; Proudfoot et al., 2001) , and %)!KKLENKSK%)( (HBD-2) in the polyprotein of BVDV strain Pe515, both may be potential heparin-binding sites. Both of these regions of basic amino acids are conserved among all the BVDV strains for which data have been deposited in sequence databases. To determine whether the basic amino acid residues in these potential heparin-binding motifs are indeed responsible for E rns -GAG-binding activity, a series of single and double mutants, generated by sitedirected mutagenesis by substituting lysine with neutral residues, and a single deletion mutant (a deletion of 15 amino acids, 480-494) were made. A total of 11 single, double and deletion mutants was constructed (Fig. 1) .
Effect of E rns mutation on heparin-binding affinity
The relative affinities of the recombinant proteins for heparin were assessed by chromatography on heparin-agarose columns. Wild-type and mutant E rns proteins were expressed in Drosophila S2 cells and culture supernatants were applied to heparin-agarose columns and eluted with a stepwise gradient of an increasing concentration of NaCl (0n1-1n0 M). Wild-type and E rns mutants, K%!'A-K%!(T, K%!'A, K%!(T and K%!*G, in which basic amino acids had been substituted in the first potential HBD, HBD-1, and two mutants, K%)!A and K%)(G, from the second potential HBD, HBD-2, eluted between 0n5 and 1n0 M NaCl. These results indicated that the heparinbinding affinity of these E rns mutants was like wild-type E rns (Fig. 2a) . In contrast, the other mutants from HBD-2, K%)!A-K%)"T, K%)&A-K%)(G, K%)"T and K%)&A and the deletion mutant ∆480-494 eluted from the matrix at 0n2-0n4 M NaCl (Fig. 2b) and showed reduced heparin binding. From these results we deduce that two basic residues of E rns , Lys%)" and Lys%)&, are critical for binding to the heparin matrix.
E rns mutants that lack heparin-binding ability retain their RNase activity
To ensure that the changes introduced into E rns did not induce extensive conformational change to the molecule, the ribonuclease activity of E rns was examined. The specific ribonuclease activities of the purified wild-type and E rns Fig. 2 . Binding activities of E rns mutants to heparin-agarose. The relative binding of E rns mutants to heparin was estimated by the concentration of NaCl required for elution from a heparin-agarose column. Culture supernatants from Drosophila S2 cells expressing wild-type and mutant E rns proteins were applied to a heparin-agarose column and the E rns protein was eluted with a stepwise NaCl gradient (0n1-1n0 M). The fractions were assayed for E rns by ELISA. Total eluted E rns for each mutant from each NaCl concentration is shown. (a) E rns mutants that had no effect on their binding to heparin-agarose : wild-type (black), K mutants K%)!A-K%)"T, K%)&A-K%)(G, K%)"T and K%)&A and the deletion mutant ∆480-494 were : 756, 822, 634, 712, 568 and 613 A #'! units per min per mg, respectively. These results demonstrated that mutant E rns showed no significant loss of ribonuclease activity.
Effect of E rns mutations on binding to the cell surface
The E rns mutants were examined for their differences in cell surface binding. Purified recombinant proteins were incubated with paraformaldehyde-fixed CTe cells and the relative binding of mutant proteins was analysed by ELISA. The data, shown in Fig. 3 , demonstrated that wild-type and six mutants of glycoprotein E rns (K%!'A-K%!(T, K%!'A, K%!(T, K%!*G, K%)!A and K%)(G) showed similar binding to CTe cells but mutants K%)!A-K%)"T, K%)&A-K%)(G, K%)"T and K%)&A and the deletion mutant ∆480-494 had lost their ability to bind to the surface of cells. These results show that residues Lys%)" and Lys%)& are important residues involved in binding to cell surface GAGs. Notably, the ability of E rns to bind to cells correlates with their affinity for immobilized heparin. Fig. 4 . Effect of amino acid substitutions in the E rns protein on its ability to inhibit BVDV infection. E rns mutants were tested for their ability to block virus infection by treating the CTe cells with wild-type E rns , mutant E rns or GFP/V5 (control) for 1 h at 37 mC. Cells were then inoculated with approximately 75 p.f.u. of CP BVDV. The final concentration of E rns , mutant E rns or GFP/V5 was diluted to 20 µg/ml and incubated for a further 1 h. The cells were then washed and overlaid with medium containing 1 % agarose. After incubation for 3 days, the cells were fixed and stained and the plaques counted. Error bars show the standard deviations from triplicate data points.
Ability of mutant E rns to block virus infectivity
To determine whether the observed impairment of E rns mutants in cell surface binding and binding to immobilized heparin also correlated with inhibition of virus infection, CTe cells were incubated with wild-type and mutant proteins and subsequently infected with CP BVDV virus. As shown in Fig.  4 , the addition of wild-type E rns and mutant E rns , K%!'A-K%!(T, K%!'A, K%!(T, K%!*G, K%)!A and K%)(G during the period of virus attachment reduced plaque formation. In contrast, E rns mutants K%)!A-K%)"T, K%)&A-K%)(G, K%)"T and K%)&A and the deletion mutant ∆480-494 showed no significant inhibitory effect on virus infection compared to the GFP\V5 negative control protein. Hence, we conclude that E rns mutants with lysine residues at positions 481 and 485 changed to neutral amino acid residues were defective in heparin and cell surface binding and also lost their ability to block virus infection.
Discussion
Recently we showed that BVDV glycoprotein E rns binds to immobilized heparin and interacts with cell surface heparan sulphate-like GAGs and proposed that BVDV interacts initially with the infected cell through this mechanism (Iqbal et al., 2000) . In this report, we localized a functional site on E rns that is involved in binding to cell surface GAGs and we determined the relative importance of positively charged residues in two potential HBDs (%!'KKGK%!* and %)!KKLENKSK%)() of E rns . The results from site-directed mutagenesis of E rns presented here indicated that binding of the E rns to GAGs involves lysine residues at positions 481 and 485 of the virus polyprotein, the motif at residues 406-409 had no effect on GAG binding.
In CSFV, strain Brescia, Hulst et al. (2000) observed that the affinity of the virus for heparin increased after passage in tissue culture. These authors showed that residue 476 was involved in determining the affinity of the virus for heparin, since, on adaptation to tissue culture, this residue changed from Ser to Arg : this residue is adjacent to the heparin-binding motif that we have identified here for BVDV. At position 476, strains of CSFV vary with lysine, arginine or serine residues present but all BVDV and BDV sequences deposited in sequence databases are distinct and have glycine at that position. (In this study, we have not examined the effect of changing the conserved glycine at position 476 of BVDV E rns .) Like residue 476, the region we have identified (%)!KKLENK%)') as a GAG-binding site is totally conserved in all BVDV strains sequenced to date. As a comparison with the examples from sequence databases, we have examined the amino acid sequence of this region of BVDV E rns directly from the serum of three persistently infected calves. RT-PCR and sequencing the cDNA products prepared from serum samples showed a conserved amino acid sequence between residues 470 and the C terminus of E rns in the region of the GAG-binding motif we have identified (data not shown). We submit, therefore, that adaptation of BVDV to tissue culture does not select for mutations around the GAGbinding motif and changes in binding to GAGs ; this contrasts with observations made on CSFV (Hulst et al., 2000) . This GAG-binding motif is also highly conserved in BDV isolates : the only variation has been observed is residue 485. In BDV, residue 485 may be asparagine (as observed in BVDV) or histidine, which makes the BDV consensus KKLE N \ H K. This region is somewhat different in CSFV isolates. The sequence CBFG Heparin-binding sites of BVDV E rns Heparin-binding sites of BVDV E rns reported most frequently in this region for CSFV isolates is KRLEGR but the consensus sequence can be described as
Notably, in all pestiviruses the LE motif is totally conserved. The significance of the change between CSFV and the BVDV\BDV group is unclear but it may correlate with the fine specificity of GAG binding and the important influence of residue 476 in CSFV.
The GAG-binding motif for all pestiviruses can be summarized as BBLEXBSB. This sequence does not exactly match any of the motifs for heparin binding adduced by Hileman et al. (1998) . Similarly this region of E rns does not match the other motifs : the XBBBXBX motif, typified by IL8, or the TXXBXXTBXXXTBB motif, typified by fibroblast growth factors.
There is a wide range of diverse interactions between cell surface proteoglycans and proteins or glycoproteins. Normal physiological interactions range from coagulation cascades, growth factor signalling and cell adhesion to lipase binding (Davies et al., 2001 ; Feldman et al., 2000 ; Hirose et al., 2001 ; Hussain et al., 2000 ; Koyama et al., 1991 ; Wuppermann et al., 2001) . Likewise, viruses interact with proteoglycans in a number of ways. Several viruses may use cell surface proteoglycans as a step in virus attachment to cells but other virus molecules are not involved in the binding of virus to cells. Two well-studied examples of virus particles binding to GAGs are worth considering.
The importance of binding to cell surface GAGs of members of the family Herpesviridae in virus entry has recently been reviewed (Rajcani & Vojvodova, 1998) . Herpes simplex virus (HSV) contains at least two glycoproteins that bind to GAGs, gB and gC, and the residues involved in binding to GAGs have been identified. In the alphaherpesviruses pseudorabies virus and bovine herpesvirus-1 the gC glycoproteins contain multiple HBDs (Flynn & Ryan, 1996 ; Liang et al., 1993) , whereas the gC of HSV-1 appears to have a single GAGbinding region (Ma/ rdberg et al., 2001 ; Tal-Singer et al., 1995 ; Trybala et al., 1994) . Clearly, at least some herpesviruses interact with GAGs through multiple proteins in multiple interactions.
On the other hand, the crystal structure of foot-and-mouth disease virus (FMDV) associated with GAGs has revealed that there is a single site of interaction between GAGs and the virus particle. The interaction is formed by three virus capsid proteins (Fry et al., 1999) with special importance associated with arginine at position 56 of VP3. This residue in field strains is histidine but arginine is selected on passage in tissue culture, which parallels an increased affinity for heparin but attenuation for cattle (Sa-Carvalho et al., 1997) . The adaptation of FMDV to tissue culture may be analogous to the adaptation of CSFV to tissue culture. There is no structural information available for pestivirus glycoproteins and whether variation in the affinity of the E rns glycoprotein of BVDV for GAGs affects virulence is not known. For BVDV and BDV, we do not know whether there is a selective pressure in culture to increase the affinity of the virus for GAGs. However, the highly conserved nature of the GAG-binding region in both BVDV and BDV and the absence of the variant amino acids in that region observed in CSFV prompts us to suggest that adaptation of GAG binding in tissue culture is not a major issue. However, the mutation of a single region in BVDV E rns and the alteration of the affinity for heparin in CSFV close to this site suggest that there is a single GAG-binding motif in E rns .
The binding of cytokines and growth factors to GAGs is thought to be an important mechanism favouring a paracrine action rather than a systemic action. It is hypothesized that binding to sulphated polysaccharides may focus the action of soluble polypeptides locally. Examples include many interleukins (for example, see Mummery & Rider, 2000) and IFN-γ (Lortat-Jacob & Grimaud, 1991 ; Lortat-Jacob et al., 1995) . Interaction with proteoglycans local to the site of infection also may be an important way for viruses to influence their local environment. This strategy seems to have been utilized by some poxviruses. Many secreted poxvirus proteins bind to GAGs ; examples include a complement control protein (Smith et al., 2000) and the chemokine antagonists MC148 from Molluscum contagiosum (Damon et al., 1998) and MT-1 from myxoma virus (Seet et al., 2001) . The GAG-binding activity of these virus proteins may well retain the activity of these polypeptides local to the site of virus infection acting in a paracrine fashion.
E rns is a structural component of the virus particle but it is also secreted from infected cells. E rns has the opportunity to act not only in virus entry but also as a paracrine mediator of an undefined activity. It is possible that an unknown function of E rns as a secreted glycoprotein may require its GAG-binding activity. Whether such a function is required during the acute phase of infection or in establishing a persistent infection is open to investigation. Identification of the residues involved in the interaction between E rns and glycosaminoglycan proteoglycans should promote the design of experiments to dissect the function of this glycoprotein in the natural history of pestiviruses.
